Rick Shea admitted on a webcast a few months ago that the Lovenox capacity constraint is deliberate and the rationale is to avert an authorized generic launch by SNY.
MNTA executives mention this capacity constraint prominently on many webcasts because they know people from SNY are listening in.
News 
Market Data 
Discover 
AI
